Horsham, PA, United States of America

Cell Pathways

Calculating rank
USPTO Granted Patents = 75

% Expired Patents = 13.3

Forward Citations = 808

Loading Chart...
Loading Chart...

22 inventors (with patents filed for the assignee):

goldMedal Rifat Pamukcu (67 out of 74 patents)

silverMedal Gary A Piazza (54 out of 58 patents)

bronzeMedal Gerhard J Sperl (22 out of 24 patents)

4.  Paul Gross (17 out of 19 patents)

5.  Klaus Brendel (16 out of 21 patents)

6.  W Joseph Thompson (7 out of 8 patents)

7.  Kerstin B Menander (6 out of 8 patents)

8.  Han Li (4 out of 15 patents)

9.  Li Liu (3 out of 3 patents)

10.  Ulrich Ixkes (3 out of 3 patents)

11.  Xiaojing Michael Wang (2 out of 13 patents)

12.  Hector W Alila (2 out of 4 patents)

13.  Keith A Earle (2 out of 3 patents)

14.  Clark M Whitehead (2 out of 2 patents)

15.  Mark Jeffrey Mayle (2 out of 2 patents)


Core Competencies:
Neoplasia
Cancer Treatment
Renal Cell Carcinoma
Precancerous Lesions
Pharmaceutical Compositions
Vinca Alkaloids
Isoquinoline Derivatives
Benzimidazole Derivatives
Purin-6-Ones
Phenyl Quinazolinone
Paclitaxel Derivatives
Indole Derivatives

75 patents:

Company Overview
Cell Pathways, based in Horsham, PA, specializes in the development of innovative treatments for neoplasia, focusing on various forms of cancer, including renal cell carcinoma and precancerous lesions. The company is dedicated to advancing pharmaceutical compositions that leverage the therapeutic potential of vinca alkaloids, isoquinoline derivatives, and benzimidazole derivatives. Through its research, Cell Pathways aims to provide effective solutions that enhance patient outcomes in oncology.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

Cell Pathways USPTO Patent Assignee Logo
75 Patents

#4 in Horsham, PA

#186 in Pennsylvania

#4,920 in US

#10,028 in the World

Horsham, PA (US)
Horsham, PA, United States of America
Forward Citations = 808

22 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cell Pathways. Retrieved from https://idiyas.com/company/cell-pathways

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…